Last edition
News about Global Pharma
Cellarity Appoints Ted Myles as Chief Executive Officer
Cellarity and Flagship Pioneering have appointed veteran biopharma executive Ted Myles as Chief Executive Officer of Cellarity and CEO-Partner at Flagship, as the company prepares to enter clinical development with its lead AI-driven program.
Global Pharma | 12/05/2025 | By Manvi | 312
Mediso Completes First Phase of MRI Tech Transfer Agreement with SSI
Mediso announced the successful completion of the first phase of a strategic technology transfer agreement with Superconducting Systems Inc. (SSI), a fully owned subsidiary of IMRIS. This agreement marks a significant milestone in Mediso's long-term commitment to vertical integration and innovation in the field of MRI system development.
Global Pharma | 12/05/2025 | By Manvi | 304
FDA Approves Teal Wand, First At-Home Cervical Cancer Screening Device
Teal Health®, a women's health company on a mission to eliminate cervical cancer, announced the Food and Drug Administration's (FDA) approval of the Teal Wand™, the first and only at-home vaginal sample self-collection device for cervical cancer screening in the United States.
Global Pharma | 12/05/2025 | By Manvi | 267
US President to Announce Prescription Drug Price Cut by up to 80 Percent
The United States of America will grow and make huge profits after President Donald Trump signed the executive order lowering prescription drug and pharmaceutical prices.
Global Pharma | 12/05/2025 | By Manvi | 165
US Pharma Import Tariffs May Hit Indian Pharma Companies
The proposed new tariff by the United States of America on pharma imports may affect Indian pharmaceutical majors. Shares of many pharmaceutical brands tumbled.
Global Pharma | 12/05/2025 | By Manvi | 1417
Agilent Launches First India Solution Center in Manesar to Drive Innovation and Growth
Agilent announced the opening of its first-ever India Solution Center at its LEED Platinum-certified office in Manesar, Haryana. Designed to provide integrated solutions, this strategic investment marks a major milestone in Agilent’s global journey, highlighting strong focus on India as a high-growth, innovation-driven market.
Global Pharma | 09/05/2025 | By Manvi | 246
Refeyn Installs 500th Mass Photometry System, Marking Major Milestone in Bioanalytics
Refeyn, the company behind pioneering mass photometry technology, has announced the installation of the 500th system based on its novel single-particle bioanalytical technology – notably, within just seven years of its spin out from Oxford University in 2018.
Global Pharma | 09/05/2025 | By Manvi | 259
India Pharma Market Grows 7.8 Percent in April: Report
The India Ratings and Research report shows that therapies such as cardiac, gastrointestinal, anti-diabetic, and dermatology received higher volume growth in April.
Global Pharma | 09/05/2025 | By Manvi | 298
Senores Pharmaceuticals Acquires ANDA for Tramadol Tablets from APDM Pharmaceuticals
Senores Pharmaceuticals has acquired the USFDA-approved ANDA for Tramadol Tablets from APDM Pharmaceuticals, using IPO proceeds to strengthen its pain management portfolio in the US market.
Global Pharma | 09/05/2025 | By Manvi | 686
Remlife Global, a Singapore-based subsidiary of Remedium Lifecare, has partnered with JiyaYu Lifesciences to replace animal-origin inputs in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates with proprietary fermentation and biocatalyst-based alternatives.
Global Pharma | 09/05/2025 | By Manvi | 255
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy